Ensuring Leadership Continuity—The Coleman Health Services Case Study is starting in

FDA-Cleared Digital Therapeutics Products – As Of 2025

As reported by the National Library of Medicine, there have been 23 digital therapeutics (DTx) approved/cleared by the U.S. Food and Drug Administration (FDA) for treating/managing/preventing a range of diseases, categorized as psychiatric, addiction, neurological, endocrinological, orthopedic diseases, and more . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Tagged As: